Based on findings in mouse experiments, Feng et al. reported that in-vitro induced IFNγ+ Treg suppress inflammation effectively when transferred to mice with colitis but differentiate to Th1 lymphocytes when adoptively transferred to mice without inflammation [16]. This evidence concerns the gene IFNG and colitis.